Japan’s genomic medicine market was valued at ~USD 2.27 B in 2024, forecast to reach USD 7.33 B by 2033 (CAGR ~13.9%) via broad NGS and diagnostic uptake. https://www.datamintelligence.com/research-report/japan-genomic-medicine-market